Ascentage Pharma Group In... (AAPG)
18.31
-0.66 (-3.48%)
At close: Mar 25, 2025, 3:59 PM
18.59
1.54%
After-hours: Mar 25, 2025, 05:26 PM EDT
-3.48% (1D)
| Bid | 17.96 |
| Market Cap | 1.59B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.7 |
| PE Ratio (ttm) | -26.16 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 18.96 |
| Volume | 13,010 |
| Avg. Volume (20D) | 142,921 |
| Open | 18.96 |
| Previous Close | 18.97 |
| Day's Range | 18.31 - 18.96 |
| 52-Week Range | 16.50 - 21.40 |
| Beta | 1.05 |
About AAPG
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; A...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 24, 2025
Employees 574
Stock Exchange NASDAQ
Ticker Symbol AAPG
Website https://www.ascentage.cn